Warning: fopen(/home/virtual/colon/journal/upload/ip_log/ip_log_2024-11.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 95 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 96
Division of Colorectal Surgery, Philippine General Hospital, University of the Philippines Manila, Manila, Philippines
Copyright © 2021 The Korean Society of Coloproctology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
Characteristic | No. of patients (%) |
---|---|
Sex | |
Male | 22 (42.3) |
Female | 30 (57.7) |
Age (yr) | |
< 30 | 2 (3.8) |
30–49 | 15 (28.8) |
50–69 | 28 (53.8) |
> 69 | 7 (13.5) |
Residence | |
Within the capital | 21 (40.4) |
Outside the capital | 31 (59.6) |
Stage at initial presentation | |
I | 2 (3.8) |
IIA | 8 (15.4) |
IIB | 2 (3.8) |
IIC | 1 (1.9) |
IIIA | 1 (1.9) |
IIIB | 31 (59.6) |
IIIC | 7 (13.5) |
Underwent bowel diversion | |
Prior to neoadjuvant treatment | 24 (46.2) |
For palliation | 9 (17.3) |
Patient | Initial MDT plan | Eventual MDT plan | Neoadjuvant treatment | Definitive surgery | Outcome |
---|---|---|---|---|---|
1 | Systemic chemotherapy then reassess; LCCRT if with response | Neoadjuvant chemotherapy | With delay, ongoing | NA | Local progression |
2 | LCCRT | LCCRT + chemotherapy | With delay, ongoing | NA | Local progression |
3 | SCRT | LCCRT | On time | For APR, with delay | Stable disease |
4 | LCCRT | LCCRT + chemotherapy | With delay, ongoing | NA | Local progression |
5 | LCCRT | Neoadjuvant chemotherapy | With delay, ongoing | NA | Local progression |
6 | LCCRT | LCCRT + chemotherapy | On time | For ATAR, with delay | Tumor regression |
7 | LCCRT | RAPIDO | With delay, ongoing | NA | Local progression |
8 | LCCRT | LCCRT + chemotherapy | On time | For LAR, with delay | Local progression |
9 | LCCRT | Neoadjuvant chemotherapy | With delay, ongoing | NA | Local progression |
10 | Laparoscopic LAR | ATAR | NA | On time | Local progression |
With nonmetastatic rectal cancer who have undergone, or were undergoing neoadjuvant therapy; or were scheduled for surgery, prior to the imposition of the enhanced community quarantine.
MDT, multidisciplinary team; COVID-19, coronavirus disease 2019; LCCRT, long-course chemoradiotherapy; NA, not applicable; SCRT, short-course radiotherapy; RAPIDO, SCRT with neoadjuvant chemotherapy; APR, abdominoperineal resection; ATAR, abdominotransanal resection; LAR, low anterior resection.